JP4614457B2 - Topical skin disease - Google Patents
Topical skin disease Download PDFInfo
- Publication number
- JP4614457B2 JP4614457B2 JP2006326845A JP2006326845A JP4614457B2 JP 4614457 B2 JP4614457 B2 JP 4614457B2 JP 2006326845 A JP2006326845 A JP 2006326845A JP 2006326845 A JP2006326845 A JP 2006326845A JP 4614457 B2 JP4614457 B2 JP 4614457B2
- Authority
- JP
- Japan
- Prior art keywords
- dried
- stock solution
- mixed
- skin disease
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 208000017520 skin disease Diseases 0.000 title claims description 6
- 230000000699 topical effect Effects 0.000 title description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 14
- 238000002360 preparation method Methods 0.000 claims description 14
- 239000006210 lotion Substances 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 239000000284 extract Substances 0.000 claims description 9
- 235000013399 edible fruits Nutrition 0.000 claims description 8
- 235000011187 glycerol Nutrition 0.000 claims description 7
- 239000011550 stock solution Substances 0.000 claims description 7
- 240000000691 Houttuynia cordata Species 0.000 claims description 6
- 235000013719 Houttuynia cordata Nutrition 0.000 claims description 6
- 239000006071 cream Substances 0.000 claims description 6
- 239000000344 soap Substances 0.000 claims description 6
- 235000019501 Lemon oil Nutrition 0.000 claims description 5
- 244000269722 Thea sinensis Species 0.000 claims description 5
- 125000003118 aryl group Chemical group 0.000 claims description 5
- 239000010501 lemon oil Substances 0.000 claims description 5
- 235000020083 shōchū Nutrition 0.000 claims description 5
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims description 4
- 240000006891 Artemisia vulgaris Species 0.000 claims description 4
- 235000019502 Orange oil Nutrition 0.000 claims description 4
- 235000009569 green tea Nutrition 0.000 claims description 4
- 239000010502 orange oil Substances 0.000 claims description 4
- 241000195955 Equisetum hyemale Species 0.000 claims description 3
- 239000003921 oil Substances 0.000 claims description 3
- 235000019198 oils Nutrition 0.000 claims description 3
- 235000009754 Vitis X bourquina Nutrition 0.000 claims description 2
- 235000012333 Vitis X labruscana Nutrition 0.000 claims description 2
- 240000006365 Vitis vinifera Species 0.000 claims description 2
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- 239000000243 solution Substances 0.000 claims description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 208000003251 Pruritus Diseases 0.000 description 5
- 239000002075 main ingredient Substances 0.000 description 5
- 201000004384 Alopecia Diseases 0.000 description 4
- 208000024963 hair loss Diseases 0.000 description 4
- 230000003676 hair loss Effects 0.000 description 4
- 235000008216 herbs Nutrition 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 241000219094 Vitaceae Species 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 210000003414 extremity Anatomy 0.000 description 3
- 235000021021 grapes Nutrition 0.000 description 3
- 239000012676 herbal extract Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010033733 Papule Diseases 0.000 description 2
- 235000017190 Vitis vinifera subsp sylvestris Nutrition 0.000 description 2
- 244000237969 Vitis vulpina Species 0.000 description 2
- 235000017242 Vitis vulpina Nutrition 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 235000003715 nutritional status Nutrition 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 210000000689 upper leg Anatomy 0.000 description 2
- 206010000117 Abnormal behaviour Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000218645 Cedrus Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000006311 Pyoderma Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 230000000895 acaricidal effect Effects 0.000 description 1
- 239000000642 acaricide Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 229940068517 fruit extracts Drugs 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000008239 natural water Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 235000021110 pickles Nutrition 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Description
本発明は、犬猫等の小型動物や馬牛等の大型動物における皮膚病治療に使用する外用剤に係わり、外用剤は薬草類と果実の抽出液を主原料とした石鹸及びローション並びにクリームに関するものである。 TECHNICAL FIELD The present invention relates to an external preparation used for the treatment of skin diseases in small animals such as dogs and cats and large animals such as horse cattle, and the external preparation relates to soaps and lotions and creams mainly using herbal extracts and fruit extracts. Is.
動物皮膚病外用剤の先行技術には、特開平6-179625号(特許文献1)、特開平10-139677号(特許文献2)、特開2001-321016(特許文献3)、特開2002-154975号(特許文献4)、特開2002-363065号(特許文献5)等がみられる。
この特許文献のうち特許文献5は本件出願人にかかるものであるが、いずれの特許文献も主として薬草を主原料とする外用治療剤に係わり、その治療効果を挙げており薬草もまた多種類である。
しかし、安定した治療剤とするためには、主原料より抽出した成分の濃度や調剤技術等が必要とされるにかかわらず配慮されていないと認められる。
Of these patent documents, Patent Document 5 is related to the applicant of the present application. However, each patent document mainly relates to a therapeutic agent for external use mainly made of medicinal herbs, and has shown its therapeutic effect. is there.
However, in order to obtain a stable therapeutic agent, it is recognized that no consideration has been given to the concentration of ingredients extracted from the main raw materials and the preparation technique.
本発明が解決しようとする問題点は、先行文献に記載される主原料の薬草や果物と同一又は類似に属するものを治療用主原料に使用するに当り、薬草から主成分を抽出する条件を共通とし、有機溶剤とグリセリンとを加えて混和を図ることにより、治療効果の安定した外用剤としようとするものである。 The problem to be solved by the present invention is that the conditions for extracting the main component from the herb are used in the case of using the same or similar to the main ingredient medicinal herb or fruit described in the prior literature as the main ingredient for treatment. It is intended to be an external preparation with a stable therapeutic effect by adding an organic solvent and glycerin and mixing them.
本件出願人は前記課題を解決するため本件出願人に係わる前記特許文献5における主原料を精査し整理して所要原料にまとめたうえ、その原料の成分抽出条件を共通とし、各抽出液の混合に当って果実のアルコール浸出液とグリセリンと芳香性果実液を加えることによりその目的を達成しようとするものである。 In order to solve the above-mentioned problems, the applicant of the present application carefully examines and arranges the main raw materials in Patent Document 5 related to the applicant and summarizes them into the required raw materials. In this process, the alcoholic leachate of fruit, glycerin and aromatic fruit liquid are added to achieve the purpose.
上記目的達成手段を具体的に記すと、原料のうち薬草はヨモギ・スギナ・緑茶葉・ドクダミ、果実は野ぶどう、芳香性果実油分はオレンジ油・レモン油の2種類である。上記4種類の薬草の抽出液を水に懸濁させるために、野ぶどうのアルコール度35°前後の焼酎漬け液とグリセリンとを使用する。 Specifically, the above means for achieving the purpose are medicinal herbs of mugwort, horsetail, green tea leaves and dokudami, fruits are wild grapes, and aromatic fruit oils are orange oil and lemon oil. In order to suspend the extracts of the above four kinds of herbs in water, shochu pickled liquor and glycerin with an alcohol degree of around 35 ° in the field grapes are used.
これら薬草は乾燥した一定重量のものを一定容量の水で煮つめて特定容量の薬効成分抽出液として使用し、野ぶどうの焼酎漬け液も上記の特定容量のものを使用する。
These medicinal herbs are boiled with a constant volume of water and used as a specific volume of medicinal component extract, and the soy pickles of field grapes also have the above specific volume .
上記薬草の抽出液とグリセリンと芳香性果実液とから成る本発明外用剤主成分の混合比は、容量比で薬草抽出液4種類とも各3、野ぶどう焼酎漬け液1、芳香性果実油分のオレンジ油3・レモン油0.3、グリセリン5である。
上記中でスギナと茶葉とドクダミの抽出液は2までに減量させることが患者患部の症状によりできる。
The mixing ratio of the above-mentioned external preparations of the present invention consisting of the herbal extract, glycerin and aromatic fruit liquid is 3 for each of the 4 types of herbal extracts, 1 in the field grape shochu pickled liquid, and the aromatic fruit oil content. Orange oil 3, lemon oil 0.3 and glycerin 5.
Among the above, the extract of cedar, tea leaves and dokudami can be reduced to 2 depending on the symptoms of the affected area of the patient.
上記主成分を混合した主原液を、ローションすなわち患部洗浄水や化粧水とする場合には水に容量比で30%の割合で混合し、クリームローションとする場合には主原液3、クリーム5、水2の割合で混和し、石鹸の場合には主成分原液3、石鹸材料4、水3の割合で混和する。
前記主原液はアルカリ性であるから使用する水は酸性でない自然水が使用される。また、ローション類や石鹸化への手段についてはその業界における一般技術で行ってよい。
When the main stock solution mixed with the above main components is used as a lotion, that is, affected area washing water or lotion, it is mixed with water at a ratio of 30% by volume, and when it is used as a cream lotion, the main stock solution 3, cream 5, Mix in the proportion of water 2 and in the case of soap, mix in the proportion of the main ingredient stock solution 3, soap material 4, and water 3.
Since the main stock solution is alkaline, natural water that is not acidic is used. In addition, lotions and soaping means may be performed by general techniques in the industry.
本件出願人の出願にかかわる前記特許文献5ではその発明の効果を(表1)に示している。すなわち、犬の治療効果は重傷3〜4ヵ月、中傷1〜1.5ヵ月、軽傷1ヵ月以内、最長日数4.5ヵ月、最短日数10日である。本件発明による治療では上記により少なくとも10%以上短縮した結果を得ている。 In Patent Document 5 relating to the applicant's application, the effects of the invention are shown in (Table 1). That is, the therapeutic effect of dogs is 3-4 months for serious injuries, 1-1.5 months for slander, 1 month for minor injuries, 4.5 months for the longest day, and 10 days for the shortest day. In the treatment according to the present invention, the above results have been shortened by at least 10%.
上記効果の実例を記すと、本件発明の外用剤使用前の犬(雄1才・体重7kg・雑種)の既往歴は、
平成15年7月4日、鼻鏡に赤い発疹様のものが出現。更に眼の周りがただれてきたので近医(A病院)を受診したが、蚊に刺されたとの判断で経過観察となる。四肢及び全身に掻痒性が出現し、25日、再び受診したところ、アレルギーとの判断で抗生物質を投与される。掻痒性は悪化し、掻破した部分(おもに四肢)が出血して腫脹し、脱毛が始まったのでB病院に代えた。そこで膿皮症と判断され、抗生物質、かゆみ止め、ステロイドを投与されるも症状は悪化し、8月の中旬までには全身の大部分の被毛が脱落した。かゆみのために食欲も減退し、栄養状態が極めて悪くなった。B病院の内服治療に効果を感じず、C病院に代え、毛包虫症と判断され抗生物質と殺ダニ剤、シャンプー剤の処方を受けるが、病変に著変は見られず、むしろ増悪傾向をしめし、夜中の遠吠え、脱走、異常行動が始まったため、平成15年12月5日当方へ来店した。
As an example of the above effect, the history of the dog (male 1 year old, weight 7 kg, hybrid) before using the external preparation of the present invention is as follows:
On July 4, 2003, a red rash-like thing appeared on the nasal mirror. In addition, since the area around the eyes was drowned, I visited a nearby doctor (Hospital A). Pruritus appears in the limbs and the whole body, and when she visited the clinic again on the 25th, antibiotics were administered based on the judgment of allergy. The pruritus worsened, and the scratched part (mainly the extremities) bleeds and swells, and hair loss begins. Therefore, pyoderma was judged, and antibiotics, itching and steroids were given, but the symptoms worsened, and most of the whole body had fallen by mid-August. The appetite declined because of itching, and the nutritional status became extremely poor. Feels ineffective for internal treatment at Hospital B, replaces Hospital C, and is prescribed as antibiotics, acaricides, and shampoos. I went to the store on December 5, 2003 because of howling, escape, and abnormal behavior began at night.
本件発明の外用剤使用による治療経過は平成15年12月5日から開始した。ローション・クリームローション・石鹸を使用した。
(現症)
全身的に広汎な脱毛、紅潮がみられ、丘疹、血性の痂皮、掻破による出血がある。とくに顕著なのは両側面、後駆、両大腿後縁・肛門周囲、尾、四肢であり、舐性が強い。両大腿後縁から関節に至るまで広域性の脱毛と斑状の色素沈着が見られる。鼻鏡から鼻梁にかけて丘疹と掻破によって糜爛が存在するような状態になり、炎症が強い。栄養状態が悪く、痩せていて落ち着かない。
(経過)
外用療法開始翌日から掻痒性軽減し、行動が落ち着いてくる。12月19日(治療開始2週間)、脱毛は治らないものの、炎症が治まってきた。治療開始1ヵ月頃から全身の被毛がほぼ回復。栄養状態も良好になり、鼻鏡に若干炎症が残るが、2月15日完全治癒とした。体重も17kgになっていた。
The course of treatment using the external preparation of the present invention started on December 5, 2003. Lotion, cream lotion and soap were used.
(Current disease)
Extensive systemic hair loss, flushing, papules, bloody crusts, bleeding from scratches. Particularly noticeable are the bilateral side, the rear drive, both thigh trailing edges / anus, tail, and extremities, and has strong licking. Extensive hair loss and patchy pigmentation are seen from the thigh trailing edge to the joint. From the nasal mirror to the nasal bridge, the papules and scratches result in the presence of wrinkles and strong inflammation. Nutritional condition is poor, thin and restless.
(Progress)
From the day after the start of external therapy, the pruritus is reduced and the behavior becomes calm. On December 19th (2 weeks after the start of treatment), hair loss did not heal, but inflammation had subsided. Most of the whole body's hair recovered from the first month of treatment. The nutritional status improved, and the nasal mirror remained slightly inflamed, but it was completely cured on February 15. My weight was 17kg.
上記本件発明外用剤使用による治療経過を写真で示すと、図1、図2は平成15年12月8日の犬の症状を示し、図3、図4は平成16年1月16日の、図5、図6は平成16年2月15日の症状を示す。 When the treatment course by the use of the above external preparation of the present invention is shown in photographs, FIGS. 1 and 2 show the symptoms of the dog on December 8, 2003, and FIGS. 3 and 4 show the results on January 16, 2004. 5 and 6 show the symptoms on February 15, 2004.
本発明外用剤の調合の実施例を詳記すると、日陰で乾燥したヨモギ、スギナ、緑茶葉、ドクダミそれぞれ500gを水6リットルとともに400ccになるまで煮つめ個々の抽出液とする。生のドクダミを用いる場合は1.5kgとする。野ぶどうは500gをアルコール度35°の焼酎に漬け保存(好ましくは3ヵ年)した液を用いる。オレンジ油・レモン油はそれぞれの皮を乾燥させた後に粉砕し容器に入れ蒸気で蒸して湿潤させ、これを脱水機にかけて絞りとったエキスである。 The preparation examples of the preparation for external use of the present invention will be described in detail. 500 g each of mugwort, horsetail, green tea leaves and dokudami dried in the shade are boiled together with 6 liters of water to 400 cc to obtain individual extracts. When using raw dokudami, weigh 1.5kg. For the field grapes, use a solution of 500g in a shochu with an alcohol content of 35 ° (preferably 3 years). Orange oil and lemon oil are extracts obtained by drying each skin, crushing it, placing it in a container, steaming it with steam and moistening it, and then squeezing it through a dehydrator.
上記によるものの調合は、ヨモギ抽出液30ccとスギナ・緑茶葉・ドクダミ各抽出液各20ccとを水650ccに混和し、グリセリン50ccと野ぶどうの焼酎液10ccとを加えて充分に混合し、オレンジ油30ccとレモン油2ccとを添加して主原材料とする。これをローションやクリームローションや石鹸の主材料とするものである。 For the preparation of the above, 30cc mugwort extract and 20cc each extract of sugina, green tea leaves, and dokudami are mixed in 650cc water, add 50cc glycerin and 10cc wild grape shochu liquor, and mix well. Add 30cc and 2cc of lemon oil to make main ingredients. This is the main ingredient of lotion, cream lotion and soap.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006326845A JP4614457B2 (en) | 2006-12-04 | 2006-12-04 | Topical skin disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006326845A JP4614457B2 (en) | 2006-12-04 | 2006-12-04 | Topical skin disease |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2008137963A JP2008137963A (en) | 2008-06-19 |
JP4614457B2 true JP4614457B2 (en) | 2011-01-19 |
Family
ID=39599813
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006326845A Active JP4614457B2 (en) | 2006-12-04 | 2006-12-04 | Topical skin disease |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP4614457B2 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH1087504A (en) * | 1996-09-06 | 1998-04-07 | Fumio Iizuka | Production of dermatophytosis therapeutic agent |
JP2005015364A (en) * | 2003-06-25 | 2005-01-20 | Maruzen Pharmaceut Co Ltd | Anti-oxidizing composition, skin ageing-preventing composition, anti-inflammatory composition and lipid metabolism-improving composition |
JP2006045181A (en) * | 2003-11-18 | 2006-02-16 | Sekisui Chem Co Ltd | External composition for skin |
JP2006193495A (en) * | 2005-01-17 | 2006-07-27 | Kao Corp | Cosmetic |
-
2006
- 2006-12-04 JP JP2006326845A patent/JP4614457B2/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH1087504A (en) * | 1996-09-06 | 1998-04-07 | Fumio Iizuka | Production of dermatophytosis therapeutic agent |
JP2005015364A (en) * | 2003-06-25 | 2005-01-20 | Maruzen Pharmaceut Co Ltd | Anti-oxidizing composition, skin ageing-preventing composition, anti-inflammatory composition and lipid metabolism-improving composition |
JP2006045181A (en) * | 2003-11-18 | 2006-02-16 | Sekisui Chem Co Ltd | External composition for skin |
JP2006193495A (en) * | 2005-01-17 | 2006-07-27 | Kao Corp | Cosmetic |
Also Published As
Publication number | Publication date |
---|---|
JP2008137963A (en) | 2008-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI221768B (en) | Pharmaceutical composition comprising histamine H1 receptor antagonist and histamine H3 receptor antagonist providing nasal decongestant effect | |
CN105079214A (en) | Emulsion containing traditional Chinese medicine extracting solution and used for treating eczema and preparation method thereof | |
JP5908402B2 (en) | Method for preventing renal disease and treating symptoms thereof | |
JP4614457B2 (en) | Topical skin disease | |
Conrick | Neem: the ultimate herb | |
JPH01199916A (en) | Drug for external use | |
JP6240626B2 (en) | Anti-atopic dermatitis composition | |
CN103271832A (en) | Synephrine loaded multiple emulsion and preparation method thereof | |
JP4312992B2 (en) | Antiallergic agent | |
DE602004007164T2 (en) | TRANSPORT AND ABSORPTION AGENTS AND THE METHOD OF ITS MANUFACTURE FROM HEMS | |
JP2022153490A (en) | Colloidal silver combined with plant extracts for use in treating wounds and other skin conditions | |
CN103157071B (en) | Chinese herbal compound film for treating dermatomycosis and preparation method thereof | |
WO2009115216A1 (en) | Use of a component or extract from the baobab plant for skin diseases | |
CN104189681A (en) | Compounded Chinese and western medicine gel for treating bromhidrosis and preparation method of compounded Chinese and western medicine gel | |
JP2006298944A (en) | Insulin-like growth factor-1 secretagogue | |
CN1813987A (en) | Immunoreaction regulator of eliminating skin and mucous membrane irritability | |
JPH027568B2 (en) | ||
JPH11322627A (en) | Antiallergic external composition for skin | |
JPH1160465A (en) | Cosmetic containing liquid of pyroligneous acid and liquid of pyroligneous acid of bamboo | |
JP4124318B2 (en) | Antioxidants and external preparations for skin | |
CN105943587A (en) | External use type adnate elder herb ointment for treating impact injuries and sprains and preparing method thereof | |
JP2008120776A (en) | External preparation for skin | |
JPS59155306A (en) | Hair-growing promoter | |
JP2002173434A (en) | Antiallergic composition | |
KR20030021991A (en) | Acne Remedies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100817 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100825 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100914 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100917 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20101013 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20101018 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4614457 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20131029 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |